Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.
Stephens & Co. Downgrades Univest Financial to Equal-Weight, Announces $30.5 Price Target
Stephens & Co. analyst Matt Breese downgrades Univest Financial (NASDAQ:UVSP) from Overweight to Equal-Weight and announces $30.5 price target.